TNF signaling contributes to the development of nociceptive sensitization in a tibia fracture model of complex regional pain syndrome type I

Pain

Volumn 137, Issue 3, 2008, Pages 507-519

  Sabsovich, Ilya ^a   Guo, Tian Zhi ^a   Wei, Tzuping ^a   Zhao, Rong ^a   Li, Xiangqi ^a   Clark, David J ^a   Geis, Christian ^b   Sommer, Claudia ^b   Kingery, Wade S ^a,c  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Complex regional pain syndrome; Fos immunoreactivity; MicroCT scanning; Neuropathic pain; sTNF R1; Tibia fracture; TNF

Indexed keywords

PROTEIN FOS; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; COMPLEX REGIONAL PAIN SYNDROME TYPE I; CONTROLLED STUDY; ENZYME IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; MALE; MICRO-COMPUTED TOMOGRAPHY; NOCICEPTION; NONHUMAN; OSTEOLYSIS; PAIN THRESHOLD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIZATION; SIGNAL TRANSDUCTION; TIBIA FRACTURE;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; HYPERALGESIA; MALE; RATS; RATS, SPRAGUE-DAWLEY; REFLEX SYMPATHETIC DYSTROPHY; SIGNAL TRANSDUCTION; TIBIAL FRACTURES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 47249113399     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2007.10.013     Document Type: Article

References (72)

1. Abbadie C., and Besson J.M. c-fos expression in rat lumbar spinal cord during the development of adjuvant-induced arthritis. Neuroscience 48 (1992) 985-993
2. Atkins R.M., Duckworth T., and Kanis J.A. Features of algodystrophy after colles' fracture. J Bone Joint Surg 72 B (1990) 105-110
3. Bendele A.M., McComb J., Gould T., Frazier J., Chlipala E., Seely J., et al. Effects of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) alone and in combination with methotrexate in adjuvant arthritic rats. Clin Exp Rheumatol 17 (1999) 553-560
4. Bendele A.M., McComb J., Gould T., Frazier J., Chlipala E.S., Seely J., et al. Combination benefit of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) and dexamethasone or indomethacin in adjuvant arthritic rats. Inflamm Res 48 (1999) 453-460
5. Benoliel R., Eliav E., Mannes A.J., Caudle R.M., Leeman S., and Iadarola M.J. Actions of intrathecal diphtheria toxin-substance P fusion protein on models of persistent pain. Pain 79 (1999) 243-253
6. Bickerstaff D.R., Charlesworth D., and Kanis J.A. Changes in cortical and trabecular bone in algodystrophy. Br J Rheumatol 32 (1993) 46-51
7. Birklein F., Riedl B., Claus D., and Neundorfer B. Pattern of autonomic dysfunction in time course of complex regional pain syndrome. Clin Auton Res 8 (1998) 79-85
8. Blumberg H, Janig W. Clinical manifestations of reflex sympathetic dystrophy and sympathetically maintained pain. In: PD Wall, R Melzack, editors{divides}. Book Title{divides}, Vol. Volume{divides}. City{divides}: Publisher{divides}, Year{divides}. p.̂pp. Pages{divides}.
9. Bowden J.J., Garland A.M., Baluk P., Lefevre P., Grady E.F., Vigna S.R., et al. Direct observation of substance P-induced internalization of neurokinin 1 (NK1) receptors at sites of inflammation. Proc Natl Acad Sci USA 91 (1994) 8964-8968
10. Boyce B.F., Li P., Yao Z., Zhang Q., Badell I.R., Schwarz E.M., et al. TNF-alpha and pathologic bone resorption. Keio J Med 54 (2005) 127-131
11. Catheline G., Le Guen S., Honore P., and Besson J.M. Are there long-term changes in the basal or evoked Fos expression in the dorsal horn of the spinal cord of the mononeuropathic rat?. Pain 80 (1999) 347-357
12. Cunha F.Q., Poole S., Lorenzetti B.B., and Ferreira S.H. The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol 107 (1992) 660-664
13. Cunha T.M., Verri Jr. W.A., Silva J.S., Poole S., Cunha F.Q., and Ferreira S.H. A cascade of cytokines mediates mechanical inflammatory hypernociception in mice. Proc Natl Acad Sci USA 102 (2005) 1755-1760
14. Delgado A.V., McManus A.T., and Chambers J.P. Production of tumor necrosis factor-alpha, interleukin 1-beta, interleukin 2, and interleukin 6 by rat leukocyte subpopulations after exposure to substance P. Neuropeptides 37 (2003) 355-361
15. Dickerson C., Undem B., Bullock B., and Winchurch R.A. Neuropeptide regulation of proinflammatory cytokine responses. J Leukoc Biol 63 (1998) 602-605
16. Edwards CKI, Frazier J, Seely J, Gaylord H, Martin S, Amiconne A, al. E. Assessment of the major antigeniic epitopes of the recombinant human soluble p55 TNF Type I receptor: design of a novel monomeric non-immunogenic analog, sTNF-RI. Arthritis Rheum 1998;41(S58).
17. Empl M., Renaud S., Erne B., Fuhr P., Straube A., Schaeren-Wiemers N., et al. TNF-alpha expression in painful and nonpainful neuropathies. Neurology 56 (2001) 1371-1377
18. Feige U., Hu Y.L., Gasser J., Campagnuolo G., Munyakazi L., and Bolon B. Anti-interleukin-1 and anti-tumor necrosis factor-alpha synergistically inhibit adjuvant arthritis in Lewis rats. Cell Mol Life Sci 57 (2000) 1457-1470
19. Feldmann M. Development of anti-TNF therapy for rheumatoid arthritis. Nat Rev Immunol 2 (2002) 364-371
20. Grell M., Wajant H., Zimmermann G., and Scheurich P. The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor. Proc Natl Acad Sci USA 95 (1998) 570-575
21. Guo T.Z., Offley S.C., Boyd E.A., Jacobs C.R., and Kingery W.S. Substance P signaling contributes to the vascular and nociceptive abnormalities observed in a tibial fracture rat model of complex regional pain syndrome type I. Pain 108 (2004) 95-107
22. Guo T.Z., Wei T., and Kingery W.S. Glucocorticoid inhibition of vascular abnormalities in a tibia fracture rat model of complex regional pain syndrome type I. Pain 121 (2006) 158-167
23. Hildebrand T., Laib A., Muller R., Dequeker J., and Ruegsegger P. Direct three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus. J Bone Miner Res 14 (1999) 1167-1174
24. Hildebrand T., and Ruegsegger P. A new method for the model-independent assessment of thickness in three-dimensional images. J Microsc 185 (1997) 67-75
25. Hildebrand T., and Ruegsegger P. Quantification of bone microarchitecture with the structure model index. Comput Methods Biomech Biomed Eng 1 (1997) 15-23
26. Hu J.Y., and Zhao Z.Q. Differential contributions of NMDA and non-NMDA receptors to spinal Fos expression evoked by superficial tissue and muscle inflammation in the rat. Neuroscience 106 (2001) 823-831
27. Hunt S.P., Pini W., and Evan G. Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature 328 (1987) 632-634
28. Huygen F.J., De Bruijn A.G., De Bruin M.T., Groeneweg J.G., Klein J., and Zijistra F.J. Evidence for local inflammation in complex regional pain syndrome type 1. Mediators Inflamm 11 (2002) 47-51
29. Huygen F.J., Niehof S., Zijlstra F.J., van Hagen P.M., and van Daele P.L. Successful treatment of CRPS 1 with anti-TNF. J Pain Symptom Manage 27 (2004) 101-103
30. Huygen F.J., Ramdhani N., van Toorenenbergen A., Klein J., and Zijlstra F.J. Mast cells are involved in inflammatory reactions during complex regional pain syndrome type 1. Immunol Lett 91 (2004) 147-154
31. Inglis J.J., Nissim A., Lees D.M., Hunt S.P., Chernajovsky Y., and Kidd B.L. The differential contribution of tumour necrosis factor to thermal and mechanical hyperalgesia during chronic inflammation. Arthritis Res Ther 7 (2005) R807-R816
32. Jin X., and Gereau R. Acute p38-mediated modulation of tetrodotoxin-resistant sodium channels in mouse sensory neurons by tumor necrosis factor-alpha. J Neurosci 26 (2006) 246-255
33. Junger H., and Sorkin L.S. Nociceptive and inflammatory effects of subcutaneous TNFalpha. Pain 85 (2000) 145-151
34. Kajander K.C., Madsen A.M., Iadarola M.J., Draisci G., and Wakisaka S. Fos-like immunoreactivity increases in the lumbar spinal cord following a chronic constriction injury to the sciatic nerve of rat. Neurosci Lett 206 (1996) 9-12
35. Kimble R.B., Matayoshi A.B., Vannice J.L., Kung V.T., Williams C., and Pacifici R. Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period. Endocrinology 136 (1995) 3054-3061
36. Kingery W.S., Davies M.F., and Clark J.D. A substance P receptor (NK1) antagonist can reverse vascular and nociceptive abnormalities in a rat model of complex regional pain syndrome type II. Pain 104 (2003) 75-84
37. Kingery W.S., Offley S.C., Guo T.Z., Davies M.F., Clark J.D., and Jacobs C.R. A substance P receptor (NK1) antagonist enhances the widespread osteoporotic effects of sciatic nerve section. Bone 33 (2003) 927-936
38. Kitazawa R., Kimble R.B., Vannice J.L., Kung V.T., and Pacifici R. Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice. J Clin Invest 94 (1994) 2397-2406
39. LaMotte C. Distribution of the tract of Lissauer and the dorsal root fibers in the primate spinal cord. J Comp Neurol 172 (1977) 529-561
40. Leah J.D., Porter J., de-Pommery J., Menetrey D., and Weil-Fuguzza J. Effect of acute stimulation on Fos expression in spinal neurons in the presence of persisting C-fiber activity. Brain Res 719 (1996) 104-111
41. Li Y., Ji A., Weihe E., and Schafer M.K. Cell-specific expression and lipopolysaccharide-induced regulation of tumor necrosis factor alpha (TNFalpha) and TNF receptors in rat dorsal root ganglion. J Neurosci 24 (2004) 9623-9631
42. Liang D., Li X., Lighthall G., and Clark J.D. Heme oxygenase type 2 modulates behavioral and molecular changes during chronic exposure to morphine. Neuroscience 121 (2003) 999-1005
43. Maihofner C., Handwerker H.O., Neundorfer B., and Birklein F. Mechanical hyperalgesia in complex regional pain syndrome: a role for TNF-alpha?. Neurology 65 (2005) 311-313
44. Martin S, Frazier J, Seely J, Amiconne A, Consenza ME, Rosenberg JJ, al. E.A genetically modified tumor necrosis factor receptor I (sTNF-RI) that does not elicit antibody response in primates. Arthritis Rheum 1998;41(S58).
45. Mashiba T., Burr D.B., Turner C.H., Sato M., Cain R.L., and Hock J.M. Effects of human parathyroid hormone (1-34), LY333334, on bone mass, remodeling, and mechanical properties of cortical bone during the first remodeling cycle in rabbits. Bone 28 (2001) 538-547
46. McComb J., Gould T., Chlipala E., Sennelo G., Frazier J., Kieft G., et al. Antiarthritic activity of soluble tumor necrosis factor receptor type I forms in adjuvant arthritis: correlation of plasma levels with efficacy. J Rheumatol 26 (1999) 1347-1351
47. McDonald D.M. Neurogenic inflammation in the rat trachea. I. Changes in venules, leucocytes and epithelial cells. J Neurocytol 17 (1988) 583-603
48. Menetrey D., Gannon A., Levine J.D., and Basbaum A.I. Expression of c-fos protein in interneurons and projection neurons of the rat spinal cord in response to noxious somatic, articular, and visceral stimulation. J Comp Neurol 285 (1989) 177-195
49. Mense S., and Craig Jr. A.D. Spinal and supraspinal terminations of primary afferent fibers from the gastrocnemius-soleus muscle in the cat. Neuroscience 26 (1988) 1023-1035
50. Molander C., and Grant G. Laminar distribution and somatotopic organization of primary afferent fibers from hindlimb nerves in the dorsal horn. A study by transganglionic transport of horseradish peroxidase in the rat. Neuroscience 19 (1986) 297-312
51. Munnikes R.J., Muis C., Boersma M., Heijmans-Antonissen C., Zijlstra F.J., and Huygen F.J. Intermediate stage complex regional pain syndrome type 1 is unrelated to proinflammatory cytokines. Mediators Inflamm 2005 (2005) 366-372
52. Myers R.R., Campana W.M., and Shubayev V.I. The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets. Drug Discov Today 11 (2006) 8-20
53. Nanes M.S. Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology. Gene 321 (2003) 1-15
54. Nichols M.L., Allen B.J., Rogers S.D., Ghilardi J.R., Honore P., Luger N.M., et al. Transmission of chronic nociception by spinal neurons expressing the substance P receptor. Science 286 (1999) 1558-1561
55. Oyen W.J., Arntz I.E., Claessens R.M., Van der Meer J.W., Corstens F.H., and Goris R.J. Reflex sympathetic dystrophy of the hand: an excessive inflammatory response?. Pain 55 (1993) 151-157
56. Rexed B. The cytoarchitectonic organization of the spinal cord in the cat. J Comp Neurol 96 (1952) 414-495
57. Roggia C., Gao Y., Cenci S., Weitzmann M.N., Toraldo G., Isaia G., et al. Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci USA 98 (2001) 13960-13965
58. Roggia C., Tamone C., Cenci S., Pacifici R., and Isaia G.C. Role of TNF-alpha producing T-cells in bone loss induced by estrogen deficiency. Minerva Med 95 (2004) 125-132
59. Saade N.E., Massaad C.A., Ochoa-Chaar C.I., Jabbur S.J., Safieh-Garabedian B., and Atweh S.F. Upregulation of proinflammatory cytokines and nerve growth factor by intraplantar injection of capsaicin in rats. J Physiol 545 (2002) 241-253
60. Sarangi P.P., Ward A.J., Smith E.J., Staddon G.E., and Atkins R.M. Algodystrophy and osteoporosis after tibial fractures. J Bone Joint Surg Br 75 (1993) 450-452
61. Sawamura S., Kingery W.S., Davies M.F., Agashe G.S., Clark J.D., Kobilka B.K., et al. Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors. J Neurosci 20 (2000) 9242-9251
62. Sommer C., and Kress M. Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci Lett 361 (2004) 184-187
63. Sommer C., Schmidt C., and George A. Hyperalgesia in experimental neuropathy is dependent on the TNF receptor 1. Exp Neurol 151 (1998) 138-142
64. Tonussi C.R., and Ferreira S.H. Tumour necrosis factor-alpha mediates carrageenin-induced knee-joint incapacitation and also triggers overt nociception in previously inflamed rat knee-joints. Pain 82 (1999) 81-87
65. Veldman P.H.J.M., Reynen H.M., Arntz I.E., and Goris R.J.A. Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients. Lancet 342 (1993) 1012-1016
66. Vogel C., Stallforth S., and Sommer C. Altered pain behavior and regeneration after nerve injury in TNF receptor deficient mice. J Peripher Nerv Syst 11 (2006) 294-303
67. Weinberg A.D., and Montler R. Modulation of TNF receptor family members to inhibit autoimmune disease. Curr Drug Targets Inflamm Allergy 4 (2005) 195-203
68. Woolf C.J. Central terminations of cutaneous mechanoreceptive afferents in the rat lumbar spinal cord. J Comp Neurol 261 (1987) 105-119
69. Woolf C.J., Allchorne A., Safieh-Garabedian B., and Poole S. Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha. Br J Pharmacol 121 (1997) 417-424
70. Woolf C.J., and Fitzgerald M. Somatotopic organization of cutaneous afferent terminals and dorsal horn neuronal receptive fields in the superficial and deep laminae of the rat lumbar spinal cord. J Comp Neurol 251 (1986) 517-531
71. Yamazaki Y., Maeda T., Someya G., and Wakisaka S. Temporal and spatial distribution of Fos protein in the lumbar spinal dorsal horn neurons in the rat with chronic constriction injury to the sciatic nerve. Brain Res 914 (2001) 106-114
72. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110